Publisher: Daniel Carlat, MD

Editor-in-Chief: Chris Aiken, MD

Deputy Editor: Talia Puzantian, PharmD, BCPP, professor, Keck Graduate Institute School of Pharmacy in Claremont, CA

Editorial Board:

Ronald C. Albucher, MD, clinical associate professor of psychiatry, Stanford University in Palo Alto, CA

Osman M. Ali, MD, staff psychiatrist, VA North Texas Health Care System; associate professor, department of psychiatry, UT Southwestern Medical Center in Dallas, TX

Richard Gardiner, MD, psychiatrist in private practice in Palm Desert, CA

Michael Kligman, MD, psychiatrist in Salt Lake City, UT

Alan D. Lyman, MD, child and adolescent psychiatrist in private practice in New York City, NY

James Megna, MD, PhD, DFAPA, director of inpatient psychiatry, professor departments of psychiatry, medicine, and public health & preventive medicine at SUNY Upstate Medical University in Syracuse, NY

Michael Posternak, MD, psychiatrist in private practice in Boston, MA

Sarah Rivelli, MD, FACP, FAPA, medical-psychiatry and consultation-liaison psychiatry, Virginia Tech Carilion School of Medicine and Carilion Clinic in Roanoke, VA

Glen Spielmans, PhD, associate professor of psychology, Metropolitan State University in St. Paul, MN

Marcia L. Zuckerman, MD, outpatient psychiatrist at Hallmark Health in Medford, MA; clinical assistant professor in psychiatry at Tufts School of Medicine in Boston, MA

All editorial content is peer reviewed by the editorial board. Dr. Carlat, Dr. Aiken, Dr. Puzantian, Ms. Fogelson, Ms. Martin, Ms. Zambrano, Dr. Albucher, Dr. Ali, Dr. Gardiner, Dr. Kligman, Dr. Lyman, Dr. Megna, Dr. Posternak, Dr. Rivelli, Dr. Spielmans, and Dr. Zuckerman have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity. This CME/CE activity is intended for psychiatrists, psychiatric nurses, psychologists, and other health care professionals with an interest in the diagnosis and treatment of psychiatric disorders.

Carlat Publishing occasionally uses artificial intelligence (AI) tools, such as ChatGPT and Bard, in various stages of our content creation process, such as editing articles and creating preliminary drafts and outlines. In all cases, our content is extensively revised during the editorial process by human clinicians and by our board of medical experts to ensure quality and accuracy.

As of May 2023